Infinity Pharma teams up with AbbVie for cancer drug

Wednesday, 3 Sep 2014 | 1:35 PM ET

Infinity Pharma will receive $275 million upfront from AbbVie, as part of a new venture to develop blood cancer treatments. Infinity CEO Adelene Q. Perkins, explains the significance of the deal, with CNBC's Meg Tirrell.